Table 1 Number of prior prophylactic treatments and headache days per month at baseline.

From: Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study

Number of prior prophylactics

n (%)

Number of prior prophylactic drugs (n = 119)

0

4 (3.4%)

1

15 (12.6%)

2

17 (14.3%)

3

28 (23.5%)

4

17 (14.3%)

5

13 (10.9%)

6

11 (9.2%)

7

8 (6.7%)

8

2 (1.7%)

9

2 (1.7%)

10

0 (0%)

11

1 (0.8%)

12

0 (0%)

13

1 (0.8%)

Number of days

N (%)

Headache days per month at baseline (n = 118)

0–5

1 (0.8%)

6–10

23 (19.5%)

11–15

19 (16.1%)

16–20

23 (19.5%)

21–25

8 (6.8%)

26–30

44 (37.3%)